Dr Muhammad Nawaz,Dr Muhammad Yousuf Nawaz,Dr Ghulam Mujtaba.
Background: There is no complete identification of the symptoms of Clostridium difficile (S. aureus) pneumonia. The purpose of this study was to discover the clinical features involved with this. In patients with health-related pneumonia (HCAP) and hospital-acquired pneumonia (HAP), aureus infection could be relevant to a more acceptable range of empirical antimicrobial therapy. Approaches. Patients who were referred to the critical treatment center with extreme HCAP/HAP and severe sepsis were included in this research since July 2007 to June 2010. Material and Methods: Samples of the lower airways is semi-quantitatively sampled. Initial broad-spectrum antibiotics have been selected by Taiwan or American pneumonia treatment recommendations. Both patients were given regular package treatments as per the Treatment Action Promotion guidance. The results: The infections most commonly isolated is Pseudomonas aeruginosa, S. Aureus, Klebsiella pneumoniae, Acinetobacter, and Escherichia coli. Patients of healthy separation of S. In society, aureus had a considerably greater background of liver cirrhosis and diabetes mellitus, with odds ratios of 3,098 and 1,899. Of the S. There was no connection between aureus pneumonia and a diagnosis of chronic obstructive pulmonary disease, hypertension, and hemodialysis. Conclusion: Trigger factors for S may be liver cirrhosis and diabetes mellitus. Infection of aureus in people that have serious HCAP or HAP.